Oral Session 1-16B Fungal Infection

[OS1-16B-4] Efficacy of MCFG in D-index guided early antifungal therapy; a subgroup analysis of CEDMIC trial

Shunichi Kimura¹, Yoshinobu Kanda^1,2, Masaki Iino³, Takahiro Fukuda⁴, Emiko Sakaida⁵, Tatsuo Oyake⁶, Hiroki Yamaguchi⁷, Shinichiro Fujiwara², Junji Suzumiya⁸, Akinao Okamoto⁹, Hiroyuki Fujita¹⁰, Yasushi Takamatsu¹¹, Yoshio Saburi¹², Itaru Matsumura¹³, Jun Yamanouchi¹⁴, Souichi Shiratori¹⁵, Moritaka Gotoh¹⁶, Shingen Nakamura¹⁷, Kazuo Tamura¹⁸ (1.Division of Hematology, Jichi Medical University Saitama Medical Center, 2.Division of Hematology, Department of Medicine, Jichi Medical University, 3.Department of Hematology, Yamanashi Prefectural Central Hospital, 4.Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, 5.Department of Hematology, Chiba University Hospital, 6.Hematology and Oncology, Iwate Medical University School of Medicine, 7.Department of Hematology, Nippon Medical School, 8.Department of Oncology and Hematology, Shimane University Hospital, 9.Department of Hematology, Fujita Health University School of Medicine, 10.Department of Hematology, Saiseikai Yokohama Nanbu Hospital, 11.Medical Oncology, Hematology&Infectious Diseases, Internal Medicine, Fukuoka University Hospital, 12.Department of Hematology, Oita Prefectural Hospital, 13.Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, 14.Clinical Immunology&Infectious Diseases, Ehime University Graduate School of Medicine, 15.Department of Hematology, Hokkaido University, Faculty of Medicine, 16.Department of Hematology, Tokyo Medical University, 17.Hematology, Endocrinology&Metabolism, Tokushima University Graduate School of Biomedical Sciences, 18.General Medical Research Center, Fukuoka University)